Table 1.
Meet the conditions of both clinical criteria and objective evidence of Aspergillus | |
---|---|
Clinical criteria:1+ 2 and/or 3, <1 month from onset | |
1. signs or symptoms in recent one month, the presence of at least 1 of the following: | |
a. Fever, refractory to at least 3 days or recrudescent fever after a period of defeverescence in spite of appropriate antibiotic therapy | |
b. dyspnea | |
c. Haemoptysis | |
d. Pleural friction rub or chest pain | |
e. Worsening respiratory insufficiency in spite of appropriate antibiotic therapy and ventilatory support | |
2. Radiological criteria, the presence of at least 1 of the following: | |
a. Imaging signs presented in EORTC/MSG criteria: dense, well-circumscribed lesions with or without a halo sign; air-crescent sign; cavity | |
b. Any other infiltrate on pulmonary imaging | |
3. Bronchoscopy: Tracheobronchial ulceration, nodule, pseudomembrane, plaque, or eschar seen on bronchoscopy analysis | |
Objective evidence of Aspergillus, the presence of at least 1 of the following: | |
1. A positive Aspergillus culture from low respiratory tract | |
2. A GM optical index on BALF of ≥1 | |
3. A GM optical index on serum of ≥0.5 | |
4. Recovery of Aspergillus by culture of tissue or sterile material | |
5. Histopathologic examination of a specimen obtained by biopsy in which Aspergillus hyphae were seen accompanied by evidence of associated tissue damage |
GM Galactomannan
BALF Bronchoalveolar lavage fluid